医学
利拉鲁肽
减肥
奥利斯特
不利影响
肥胖
芬特明
安非他酮
恶心
食欲
2型糖尿病
内科学
内分泌学
糖尿病
戒烟
病理
作者
Kimberly A. Gudzune,Robert F. Kushner
出处
期刊:JAMA
[American Medical Association]
日期:2024-08-20
卷期号:332 (7): 571-571
被引量:92
标识
DOI:10.1001/jama.2024.10816
摘要
Obesity affects approximately 19% of women and 14% of men worldwide and is associated with increased morbidity. Antiobesity medications (AOMs) modify biological processes that affect appetite and significantly improve outcomes, such as type 2 diabetes, hypertension, and dyslipidemia.
科研通智能强力驱动
Strongly Powered by AbleSci AI